Cryder Capital Partners Llp Lifted By $4.97 Million Its Hca Holdings (HCA) Stake; Last Week Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Coverage

June 19, 2017 - By Nellie Frank

Among 25 analysts covering Teva Pharma (NYSE:TEVA), 13 have Buy rating, 0 Sell and 12 Hold. Therefore 52% are positive. Teva Pharma had 60 analyst reports since July 21, 2015 according to SRatingsIntel. Mizuho downgraded the shares of TEVA in report on Monday, October 24 to “Neutral” rating. The stock has “Hold” rating by Maxim Group on Monday, February 13. The rating was downgraded by Maxim Group to “Hold” on Friday, January 6. The firm has “Outperform” rating given on Monday, November 14 by RBC Capital Markets. The stock has “Hold” rating by Argus Research on Tuesday, February 28. The stock has “Buy” rating by Standpoint Research on Monday, July 27. The firm has “Buy” rating given on Wednesday, November 16 by Deutsche Bank. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Buy” rating by Argus Research on Tuesday, July 28. The stock of Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) earned “Neutral” rating by BTIG Research on Wednesday, November 16. OTR Global initiated the stock with “Positive” rating in Thursday, September 29 report. See Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) latest ratings:

16/06/2017 Broker: Cantor Fitzgerald Rating: Neutral New Target: $31.00 Initiate
16/06/2017 Broker: Mizuho Old Rating: Neutral New Rating: Buy Old Target: $25.00 New Target: $30.00 Upgrade
31/05/2017 Broker: Oppenheimer Rating: Buy
26/05/2017 Broker: Mizuho Rating: Underperform Old Target: $29.00 New Target: $25.00 Target Down
15/05/2017 Broker: Deutsche Bank Rating: Buy Old Target: $45.00 New Target: $43.00 Target Down
26/04/2017 Broker: Citigroup Rating: Buy Old Target: $47.00 New Target: $42.00 Target Down
07/04/2017 Broker: BTIG Research Rating: Neutral Maintain
07/04/2017 Broker: Oppenheimer Rating: Buy New Target: $43.00 Maintain
05/04/2017 Broker: Cowen & Co Rating: Outperform New Target: $50.00 Maintain
30/03/2017 Broker: Maxim Group Rating: Outperform New Target: $35.00 Maintain

Cryder Capital Partners Llp increased Hca Holdings Inc. (HCA) stake by 21.34% reported in 2016Q4 SEC filing. Cryder Capital Partners Llp acquired 67,115 shares as Hca Holdings Inc. (HCA)’s stock declined 2.93%. The Cryder Capital Partners Llp holds 381,646 shares with $28.25 million value, up from 314,531 last quarter. Hca Holdings Inc. now has $30.41B valuation. The stock rose 0.11% or $0.09 reaching $83.5 per share. About 43,327 shares traded. HCA Healthcare Inc (NYSE:HCA) has risen 7.08% since June 19, 2016 and is uptrending. It has underperformed by 9.62% the S&P500.

About 456,808 shares traded. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) has declined 41.70% since June 19, 2016 and is downtrending. It has underperformed by 58.40% the S&P500.

Teva Pharmaceutical Industries Limited is a pharmaceutical company. The company has market cap of $32.93 billion. The Firm is engaged in developing, producing and marketing generic medicines and a portfolio of specialty medicines. It has a 294.84 P/E ratio. The Firm operates through two divisions: Generic medicines and Specialty medicines.

Among 22 analysts covering HCA Holdings (NYSE:HCA), 14 have Buy rating, 0 Sell and 8 Hold. Therefore 64% are positive. HCA Holdings had 48 analyst reports since August 6, 2015 according to SRatingsIntel. The stock of HCA Healthcare Inc (NYSE:HCA) has “Buy” rating given on Friday, August 14 by Mizuho. The firm has “Buy” rating given on Saturday, August 29 by Vetr. Barclays Capital maintained HCA Healthcare Inc (NYSE:HCA) rating on Thursday, October 8. Barclays Capital has “Overweight” rating and $94 target. The firm has “Overweight” rating given on Wednesday, January 6 by Barclays Capital. Zacks downgraded the stock to “Buy” rating in Monday, August 17 report. The rating was maintained by Leerink Swann with “Outperform” on Wednesday, October 28. RBC Capital Markets maintained HCA Healthcare Inc (NYSE:HCA) rating on Wednesday, February 1. RBC Capital Markets has “Outperform” rating and $98 target. The stock of HCA Healthcare Inc (NYSE:HCA) has “Overweight” rating given on Thursday, October 13 by KeyBanc Capital Markets. On Monday, January 4 the stock rating was downgraded by Wells Fargo to “Market Perform”. On Wednesday, June 7 the stock rating was initiated by Morgan Stanley with “Equal-Weight”.

Since January 9, 2017, it had 2 insider purchases, and 26 selling transactions for $24.13 million activity. The insider Hall Charles J sold $8.24 million. Davis Jana Joustra sold $705,836 worth of stock or 8,302 shares. Shares for $172,000 were sold by Cuffe Michael S.. $2.60 million worth of HCA Healthcare Inc (NYSE:HCA) shares were sold by STEELE JOHN M. $102,489 worth of HCA Healthcare Inc (NYSE:HCA) was sold by Torres Kathryn A. on Wednesday, May 10. The insider Perlin Jonathan B sold $5.42M. Paslick P. Martin also sold $1.88M worth of HCA Healthcare Inc (NYSE:HCA) shares.

Investors sentiment increased to 0.79 in 2016 Q4. Its up 0.12, from 0.67 in 2016Q3. It improved, as 69 investors sold HCA shares while 219 reduced holdings. 60 funds opened positions while 167 raised stakes. 263.84 million shares or 1.88% more from 258.96 million shares in 2016Q3 were reported. Sector Pension Investment Board stated it has 64,928 shares. Legal & General Group Public Ltd Liability Corporation owns 0.1% invested in HCA Healthcare Inc (NYSE:HCA) for 1.51 million shares. Amalgamated Savings Bank invested in 0.1% or 28,828 shares. Livforsakringsbolaget Skandia Omsesidigt has 0.09% invested in HCA Healthcare Inc (NYSE:HCA) for 24,482 shares. Owl Creek Asset Mngmt Lp holds 3.58% in HCA Healthcare Inc (NYSE:HCA) or 742,709 shares. Parkwood Ltd holds 0.82% or 72,208 shares. Apg Asset Mgmt Nv holds 0.21% or 1.63M shares in its portfolio. Rudman Errol M owns 77,120 shares or 3.96% of their US portfolio. Amp Capital Invsts Limited, a Australia-based fund reported 353,543 shares. Gateway Advisers Limited Liability, Ohio-based fund reported 309,612 shares. Cap Guardian Co holds 0% or 144 shares in its portfolio. Lee Danner & Bass holds 3.73% in HCA Healthcare Inc (NYSE:HCA) or 429,046 shares. Deutsche Savings Bank Ag has 0.02% invested in HCA Healthcare Inc (NYSE:HCA). Nuveen Asset Management Limited Liability Company holds 0.04% in HCA Healthcare Inc (NYSE:HCA) or 114,998 shares. Texas Permanent School Fund owns 87,549 shares for 0.09% of their portfolio.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.



Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: